Scott R. Ward - 09 Aug 2021 Form 4 Insider Report for Cardiovascular Systems Inc

Role: Chairman and CEO, Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Scott R. Ward pursuant to Power of Attorney filed herewith.
Issuer symbol: N/A
Transactions as of: 09 Aug 2021
Net transactions value: $0
Form type: 4
Filing time: 11 Aug 2021, 19:12:40 UTC
Previous filing: 11 May 2021
Next filing: 17 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSII	Common Stock	Award	$0	+33,141	+6.5%	$0.000000	540,956	09 Aug 2021	Direct	F1
transaction	CSII	Common Stock	Award	$0	+99,422	+18%	$0.000000	640,378	09 Aug 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CSII	Restricted Stock Units						34,297	09 Aug 2021	Common Stock	34,297		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restrictions lapse as to 11,047 shares on each of 8/13/22, 8/13/23 and 8/13/24.
F2	Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2022, 2023 and 2024 versus the Company's peer group.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of the Company's common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.